Home  |  Contact

UniProtKB/Swiss-Prot Q3L8U1: Variant p.Asp2312Glu

Chromodomain-helicase-DNA-binding protein 9
Gene: CHD9
Variant information

Variant position:  2312
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LB/B
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Aspartate (D) to Glutamate (E) at position 2312 (D2312E, p.Asp2312Glu).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Similar physico-chemical property. Both residues are medium size and acidic.
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  2312
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  2897
The length of the canonical sequence.

Location on the sequence:   VASFYTTKLLDSPGAATEYS  D PSVPTPPGAGVKEEHDQSTQ
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         VASFYTTKLLDSPGAATEYSDPSVPTPPGAGVKEEHDQSTQ

Mouse                         VASFYTTKLLDSPGAATERGEPSVPTPPAVAVREEHEQSAQ

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 2897 Chromodomain-helicase-DNA-binding protein 9
Region 2305 – 2337 Disordered


Literature citations

Characterization and functional analysis of CReMM, a novel chromodomain helicase DNA-binding protein.
Shur I.; Benayahu D.;
J. Mol. Biol. 352:646-655(2005)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); FUNCTION; SUBCELLULAR LOCATION; TISSUE SPECIFICITY; PHOSPHORYLATION; VARIANT GLU-2312;

PRIC320, a transcription coactivator, isolated from peroxisome proliferator-binding protein complex.
Surapureddi S.; Viswakarma N.; Yu S.; Guo D.; Rao M.S.; Reddy J.K.;
Biochem. Biophys. Res. Commun. 343:535-543(2006)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2); FUNCTION; TISSUE SPECIFICITY; VARIANT GLU-2312; INTERACTION WITH PPARA; ESR1 AND NR1I3;

Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.
Nagase T.; Ishikawa K.; Nakajima D.; Ohira M.; Seki N.; Miyajima N.; Tanaka A.; Kotani H.; Nomura N.; Ohara O.;
DNA Res. 4:141-150(1997)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 124-2897 (ISOFORM 3); VARIANT GLU-2312;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.